Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA ZYDUS LIFESCIENCES ASTRAZENECA PHARMA/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 95.5 34.2 278.9% View Chart
P/BV x 22.7 5.8 393.0% View Chart
Dividend Yield % 0.3 0.6 50.4%  

Financials

 ASTRAZENECA PHARMA   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-23
ZYDUS LIFESCIENCES
Mar-23
ASTRAZENECA PHARMA/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs3,620495 731.3%   
Low Rs2,438319 763.2%   
Sales per share (Unadj.) Rs401.2170.3 235.6%  
Earnings per share (Unadj.) Rs39.719.8 200.8%  
Cash flow per share (Unadj.) Rs46.226.9 171.7%  
Dividends per share (Unadj.) Rs16.006.00 266.7%  
Avg Dividend yield %0.51.5 35.9%  
Book value per share (Unadj.) Rs234.4173.0 135.5%  
Shares outstanding (eoy) m25.001,012.20 2.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.52.4 315.7%   
Avg P/E ratio x76.320.6 370.4%  
P/CF ratio (eoy) x65.515.1 433.2%  
Price / Book Value ratio x12.92.4 549.0%  
Dividend payout %40.330.3 132.8%   
Avg Mkt Cap Rs m75,718412,144 18.4%   
No. of employees `000NANA-   
Total wages/salary Rs m2,59124,564 10.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,030172,374 5.8%  
Other income Rs m2614,746 5.5%   
Total revenues Rs m10,291177,120 5.8%   
Gross profit Rs m1,24929,677 4.2%  
Depreciation Rs m1637,227 2.2%   
Interest Rs m61,299 0.5%   
Profit before tax Rs m1,34125,897 5.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3485,878 5.9%   
Profit after tax Rs m99320,019 5.0%  
Gross profit margin %12.517.2 72.3%  
Effective tax rate %26.022.7 114.4%   
Net profit margin %9.911.6 85.2%  
BALANCE SHEET DATA
Current assets Rs m9,359100,082 9.4%   
Current liabilities Rs m4,84455,267 8.8%   
Net working cap to sales %45.026.0 173.2%  
Current ratio x1.91.8 106.7%  
Inventory Days Days4950 98.4%  
Debtors Days Days3994 41.8%  
Net fixed assets Rs m2,061144,776 1.4%   
Share capital Rs m501,012 4.9%   
"Free" reserves Rs m5,811174,146 3.3%   
Net worth Rs m5,861175,158 3.3%   
Long term debt Rs m00-   
Total assets Rs m11,421244,940 4.7%  
Interest coverage x213.920.9 1,021.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.7 124.8%   
Return on assets %8.78.7 100.5%  
Return on equity %16.911.4 148.2%  
Return on capital %23.015.5 148.0%  
Exports to sales %039.2 0.0%   
Imports to sales %37.411.9 313.5%   
Exports (fob) Rs mNA67,577 0.0%   
Imports (cif) Rs m3,74720,544 18.2%   
Fx inflow Rs m61267,577 0.9%   
Fx outflow Rs m3,74720,544 18.2%   
Net fx Rs m-3,13547,033 -6.7%   
CASH FLOW
From Operations Rs m58326,888 2.2%  
From Investments Rs m18111,712 1.5%  
From Financial Activity Rs m-245-44,004 0.6%  
Net Cashflow Rs m519-5,338 -9.7%  

Share Holding

Indian Promoters % 0.0 75.0 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 5.4 18.0 30.1%  
FIIs % 2.7 5.0 53.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 25.0 99.9%  
Shareholders   29,032 306,495 9.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on ASTRAZENECA PHARMA vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Cadila Healthcare Share Price Performance

Period ASTRAZENECA PHARMA Cadila Healthcare S&P BSE HEALTHCARE
1-Day 0.01% 0.57% 1.18%
1-Month -3.61% 7.77% -0.75%
1-Year 59.20% 107.52% 61.82%
3-Year CAGR 20.50% 32.30% 18.16%
5-Year CAGR 22.18% 24.52% 19.79%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 16.0 per share. This amounted to a Dividend Payout ratio of 40.3%.

Cadila Healthcare paid Rs 6.0, and its dividend payout ratio stood at 30.3%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.